MassVision2050 Analysis: The Impact of AI in Healthcare & Life Sciences
NEW REPORT: Becoming the Global Leader in Applied AI for Healthcare & Life Sciences
Boston Consulting Group and Massachusetts High Technology Council—in collaboration with leaders from industry, hospitals, and academia—examine AI’s impact and chart a strategy to strengthen Massachusetts’ leading position in healthcare and life sciences.
Becoming the Global Leader in Applied AI for Healthcare & Life Sciences
NEW REPORT
Boston Consulting Group and Massachusetts High Technology Council—in collaboration with leaders from industry, hospitals, and academia—examine AI’s impact and chart a strategy to strengthen Massachusetts’ leading position in healthcare and life sciences.
Impact of Artificial Intelligence in Healthcare & Life Sciences
The digital transformation of healthcare provides an unprecedented opportunity to address the industry’s most pressing challenges, from rising costs to the growing healthcare workforce shortage.
Unlocking the full potential of this digital transformation, particularly with the evolving capabilities of Artificial Intelligence (AI), requires reimagining all components of healthcare. A systemic view is essential to rethink how drugs, medical innovations, and services are designed, developed, and delivered.
As a global leader in Healthcare, Technology, Life Sciences, and Education, Massachusetts is uniquely positioned to lead innovation and redefine the healthcare landscape, making a difference for patients in the Commonwealth and beyond.
MassVision2050: Shaping Massachusetts’ Future in Healthcare Innovation
Exploring the intersection of technology and healthcare, the Impact of Artificial Intelligence in Healthcare analysis is a groundbreaking member-led Innovation Sector project within the Massachusetts High Technology Council’s MassVision2050 initiative.
Led by the High Tech Council and in partnership with the Boston Consulting Group (BCG), this effort will assess the profound impact of AI on the healthcare and life sciences sectors in Massachusetts, spanning Biotech/Biopharma, MedTech, and Health Services.
Through collaboration with senior executives and thought leaders, we aspire to usher in a new era of AI-integrated healthcare and set the standard for an AI-integrated health ecosystem that goes beyond state boundaries. The project will articulate implications on workforce development, laying the foundation for a future-ready healthcare and life sciences workforce. Together, we strive to enable a transformation that strengthens the healthcare and life sciences ecosystems through proactive workforce development and changes in educational curricula.
Redefining the Future of Healthcare & Life Sciences with AI
Artificial Intelligence is positioned to revolutionize healthcare by accelerating innovation, improving patient outcomes, and addressing challenges in cost, quality, and access. With a market projected to grow from $450B in 2022 to ~$900B in 2027, AI, particularly GenAI, is driving new frontiers in healthcare and life sciences.
With the High Tech Council and BCG at the forefront, we are collaborating with an Advisory Board of senior executives and thought leaders from the Massachusetts healthcare and life sciences ecosystems to:
Determine AI Trends: Assess the state-of-play and AI trends reshaping the healthcare and life sciences sectors in Massachusetts.
Impact on Workforce: Evaluate the implications of AI on workforce requirements, including job capacity, skills, and competencies.
Craft Whitepaper: Develop a comprehensive whitepaper on future talent and workforce strategies for the Commonwealth.
By embracing an AI-integrated approach, we envision a future where technology and healthcare converge seamlessly, addressing challenges and paving the way for a transformative era in healthcare innovation.
Advisory Board: Voices from Across the Massachusetts Healthcare & Life Sciences Ecosystems
Our Advisory Board is comprised of senior executives and thought leaders representing organizations from the Massachusetts healthcare and life sciences ecosystems:
Brian Anderson, MD
President & CEO
Yu Cao, Ph.D.
Director, UMass Center for Digital Health
Julie Chen, Ph.D.
Chancellor
Thaddeus Guldbrandsen, Ph.D.
Dean of Sciences & Humanities
Peter Healy
President
David Luzzi, Ph.D.
Senior Vice Provost
Gabriele Ricci
Chief Data & Technology Officer
Stephen Schwartz, Ph.D.
President & CEO
Dan Shine
Senior Vice President, Analytical Instruments Group
Priya Singhal, MD
Head of Development & Interim Chief Medical Officer
David Wang
Senior Vice President & General Manager of Sample Management Solutions
Grace Wang, Ph.D.
President
Get Involved
We invite you to join us in strategizing for the future. Please contact Chris Anderson for more information.